Normocalcemic hyperparathyroidism after successful parathyroidectomy for single parathyroid adenoma: Prevalence, etiological factors, predictive markers, treatment and evolution

IF 1.8 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM
Luis García Pascual , Andreu Simó-Servat , Carlos Puig-Jové , Lluís García-González
{"title":"Normocalcemic hyperparathyroidism after successful parathyroidectomy for single parathyroid adenoma: Prevalence, etiological factors, predictive markers, treatment and evolution","authors":"Luis García Pascual ,&nbsp;Andreu Simó-Servat ,&nbsp;Carlos Puig-Jové ,&nbsp;Lluís García-González","doi":"10.1016/j.endien.2023.11.007","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and objective</h3><p>Postparathyroidectomy normocalcemic hyperparathyroidism<span><span> (PPNCHPPT) is a frequent situation for which we have no information in our country. The objective is to know our prevalence of PPNCHPPT, the associated etiological factors, the predictive markers, the </span>treatment administered and the evolution.</span></p></div><div><h3>Patients and method</h3><p>Retrospective observational cross-sectional study on 42 patients. Twelve patients with PPNCHPPT and 30 without PPNCHPPT are compared.</p></div><div><h3>Results</h3><p><span><span>HPPTNCPP prevalence: 28.6%. Etiological factors: vitamin D<span> deficiency: 75%; bone remineralization: 16.7%; renal failure: 16.7%; hypercalciruria: 8.3%. No change in the set point of calcium-mediated parathormone (PTH) secretion was observed, but an increase in the preoperative PTH/albumin-corrected calcium (ACC) ratio was observed. Predictive markers: PTH/ACC ratio (AUC 0.947; sensitivity 100%, specificity 78.9%) and PTH (AUC 0.914; sensitivity 100%, specificity 73.7%) one week postparathyroidectomy. Evolution: follow-up 30 ± 16.3 months: 50% normalized PTH and 8.3% had recurrence of hyperparathyroidism. Patients with PPNCHPPT less frequently received </span></span>preoperative treatment with </span>bisphosphonates<span> and postoperative treatment with calcium salts.</span></p></div><div><h3>Conclusions</h3><p><span>This is the first study in our country that demonstrates a mean prevalence of PPNCHPPT, mainly related to a vitamin D deficiency and a probable resistance to the action of PTH, which can be predicted by the PTH/ACC ratio and PTH a week post-intervention and often evolves normalizing the PTH. We disagree with the etiological effect of hypercalciuria and the change in the PTH/calcemia regulation set point, and we acknowledge the scant treatment administered with calcium salts in the </span>postoperative period.</p></div>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"70 10","pages":"Pages 640-648"},"PeriodicalIF":1.8000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrinologia Diabetes Y Nutricion","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2530018023001701","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objective

Postparathyroidectomy normocalcemic hyperparathyroidism (PPNCHPPT) is a frequent situation for which we have no information in our country. The objective is to know our prevalence of PPNCHPPT, the associated etiological factors, the predictive markers, the treatment administered and the evolution.

Patients and method

Retrospective observational cross-sectional study on 42 patients. Twelve patients with PPNCHPPT and 30 without PPNCHPPT are compared.

Results

HPPTNCPP prevalence: 28.6%. Etiological factors: vitamin D deficiency: 75%; bone remineralization: 16.7%; renal failure: 16.7%; hypercalciruria: 8.3%. No change in the set point of calcium-mediated parathormone (PTH) secretion was observed, but an increase in the preoperative PTH/albumin-corrected calcium (ACC) ratio was observed. Predictive markers: PTH/ACC ratio (AUC 0.947; sensitivity 100%, specificity 78.9%) and PTH (AUC 0.914; sensitivity 100%, specificity 73.7%) one week postparathyroidectomy. Evolution: follow-up 30 ± 16.3 months: 50% normalized PTH and 8.3% had recurrence of hyperparathyroidism. Patients with PPNCHPPT less frequently received preoperative treatment with bisphosphonates and postoperative treatment with calcium salts.

Conclusions

This is the first study in our country that demonstrates a mean prevalence of PPNCHPPT, mainly related to a vitamin D deficiency and a probable resistance to the action of PTH, which can be predicted by the PTH/ACC ratio and PTH a week post-intervention and often evolves normalizing the PTH. We disagree with the etiological effect of hypercalciuria and the change in the PTH/calcemia regulation set point, and we acknowledge the scant treatment administered with calcium salts in the postoperative period.

单发甲状旁腺瘤成功切除后的甲状旁腺功能亢进:患病率、病因、预测指标、治疗和演变。
背景与目的:甲状旁腺切除术后正常钙血症性甲状旁腺功能亢进(PPNCHPPT)是一种常见病,在我国尚无相关资料。目的是了解我们的PPNCHPPT的患病率,相关的病因,预测指标,给予的治疗和演变。患者与方法:42例患者的回顾性观察性横断面研究。将12例PPNCHPPT患者与30例非PPNCHPPT患者进行比较。结果:HPPTNCPP患病率为28.6%。病因:维生素D缺乏:75%;骨再矿化:16.7%;肾功能衰竭:16.7%;hypercalciruria: 8.3%。观察到钙介导的甲状旁腺激素(PTH)分泌设定值没有变化,但术前PTH/白蛋白校正钙(ACC)比值升高。预测指标:PTH/ACC比值(AUC 0.947;敏感性100%,特异性78.9%)和PTH (AUC 0.914;敏感性100%,特异性73.7%)甲状旁腺切除术后一周。进展:随访30 ± 16.3个月:50%甲状旁腺功能正常,8.3%甲状旁腺功能亢进复发。PPNCHPPT患者术前较少使用双膦酸盐治疗,术后使用钙盐治疗。结论:这是我国第一个证明PPNCHPPT平均患病率的研究,主要与维生素D缺乏和对甲状旁腺激素作用的可能抵抗有关,这可以通过干预后一周的PTH/ACC比率和PTH来预测,并且通常会使PTH正常化。我们不同意高钙尿的病因作用和PTH/钙血症调节设定点的变化,我们承认术后钙盐治疗不足。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.10
自引率
10.50%
发文量
99
期刊介绍: Endocrinología, Diabetes y Nutrición is the official journal of the Spanish Society of Endocrinology and Nutrition (Sociedad Española de Endocrinología y Nutrición, SEEN) and the Spanish Society of Diabetes (Sociedad Española de Diabetes, SED), and was founded in 1954. The aim of the journal is to improve knowledge and be a useful tool in practice for clinical and laboratory specialists, trainee physicians, researchers, and nurses interested in endocrinology, diabetes, nutrition and related disciplines. It is an international journal published in Spanish (print and online) and English (online), covering different fields of endocrinology and metabolism, including diabetes, obesity, and nutrition disorders, as well as the most relevant research produced mainly in Spanish language territories. The quality of the contents is ensured by a prestigious national and international board, and by a selected panel of specialists involved in a rigorous peer review. The result is that only manuscripts containing high quality research and with utmost interest for clinicians and professionals related in the field are published. The Journal publishes Original clinical and research articles, Reviews, Special articles, Clinical Guidelines, Position Statements from both societies and Letters to the editor. Endocrinología, Diabetes y Nutrición can be found at Science Citation Index Expanded, Medline/PubMed and SCOPUS.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信